Randall Bateman
Washington University in St. Louis
H-index: 80
North America-United States
Top articles of Randall Bateman
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Neuropsychiatric Symptoms in AD: Clinical Trials Targeting Mild Behavioral Impairment: A Report from the International CTAD Task Force | The journal of prevention of Alzheimer's disease | Maria Soto P Rosenberg C Ballard B Vellas D Miller | 2024/1 |
Deconstructing pathological tau by biological process in early stages of Alzheimer disease: a method for quantifying tau spatial spread in neuroimaging | Ebiomedicine | Stephanie Doering Austin McCullough Brian A Gordon Charles D Chen Nicole McKay | 2024/5/1 |
Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial | JAMA neurology | Olivia Wagemann Haiyan Liu Guoqiao Wang Xinyu Shi Tobias Bittner | 2024 |
Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's disease | Alzheimer's & Dementia | Guoqiao Wang Yan Li Chengjie Xiong Tammie LS Benzinger Brian A Gordon | 2024/2/23 |
Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical Trials | The Journal of Prevention of Alzheimer's Disease | Haiyan Liu J Li E Ziegemeier S Adams E McDade | 2024/3/19 |
Investigation of sex differences in mutation carriers of the Dominantly Inherited Alzheimer Network | Alzheimer's & Dementia | Olivia Wagemann Yan Li Jason Hassenstab Andrew J Aschenbrenner Nicole S McKay | 2024/1 |
α‐Synuclein seed amplification assay detects Lewy body co‐pathology in autosomal dominant Alzheimer's disease late in the disease course and dependent on Lewy pathology burden | Alzheimer's & Dementia | Johannes Levin Simone Baiardi Corinne Quadalti Marcello Rossi Angela Mammana | 2024/4/26 |
A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of … | O Mcelvaney N McEvoy F Boland OF Mcelvaney G Hogan | 2022/5 | |
Presenilin‐1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stage | Alzheimer's & Dementia | Nelly Joseph‐Mathurin Rebecca L Feldman Ruijin Lu Zahra Shirzadi Carmen Toomer | 2024/2/21 |
Clinical validation of the PrecivityAD2 blood test: A mass spectrometry‐based test with algorithm combining% p‐tau217 and Aβ42/40 ratio to identify presence of brain amyloid | Alzheimer's & Dementia | Matthew R Meyer Kristopher M Kirmess Stephanie Eastwood Traci L Wente‐Roth Faith Irvin | 2024/3/16 |
Comparison of cerebrospinal fluid, plasma and neuroimaging biomarker utility in Alzheimer’s disease | Brain Communications | Karin L Meeker Patrick H Luckett Nicolas R Barthélemy Diana A Hobbs Charles Chen | 2024 |
Cerebrospinal fluid neurofilament light chain profiling and quantitation in neurological diseases | Brain Communications | Claire A Leckey John B Coulton Tatiana A Giovannucci Yingxin He Aram Aslanyan | 2024/4/16 |
Evaluation of Exploratory Fluid Biomarker Results from a Phase 1 Senolytic Trial in Mild Alzheimer’s Disease | Miranda Orr Valentina Garbarino Juan Palavicini Justin Melendez Nicolas Barthélemy | 2024/3/8 | |
Highly Accurate Blood Test for Alzheimer’s Disease Comparable or Superior to Clinical CSF Tests | Nature Medicine | Nicolas R Barthélemy Gemma Salvadó Suzanne Schindler Yingxin He Shorena Janelidze | 2024/2/21 |
Biomarker-based staging of Alzheimer disease: rationale and clinical applications | Joseph Therriault Suzanne E Schindler Gemma Salvadó Tharick A Pascoal Andréa Lessa Benedet | 2024/3/1 | |
Use of a Blood Biomarker Test Improves Economic Utility in the Evaluation of Older Patients Presenting with Cognitive Impairment | Population Health Management | William J Canestaro Randall J Bateman David M Holtzman Mark Monane Joel B Braunstein | 2024/3/28 |
Performance of the Lumipulse plasma Aβ42/40 and pTau181 immunoassays in the detection of amyloid pathology | Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | Daniel J Figdore Heather J Wiste Joshua A Bornhorst Randall J Bateman Yan Li | 2024/1 |
Gantenerumab in Early Alzheimer's Disease. Reply. | The New England Journal of Medicine | Randall J Bateman Janice Smith Rachelle S Doody | 2024/2/1 |
Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study | The Lancet Neurology | Julie K Wisch Nicole S McKay Anna H Boerwinkle James Kennedy Shaney Flores | 2024/5/1 |
Systematic proteomics in Autosomal dominant Alzheimer's disease reveals decades-early changes of CSF proteins in neuronal death, and immune pathways | medRxiv | Yuanyuan Shen Muhammad Ali Menghan Liu Jigyasha Timsina Ciyang Wang | 2024 |
Co-Authors
